Mode
Text Size
Log in / Sign up

Network meta-analysis of balloon dilation plus adjunctive therapies for post-stroke cricopharyngeal achalasia efficacyThe Stubborn Swallowing Problem After Stroke Finally Has a Roadmap

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note varying efficacy of balloon dilation plus adjunctive therapies for post-stroke cricopharyngeal achalasia; interpret with caution.

A systematic review and network meta-analysis assessed 36 articles covering 13 interventions for patients with post-stroke cricopharyngeal achalasia. The study compared balloon dilation combined with repetitive transcranial magnetic stimulation (rTMS), electromyographic biofeedback (EMGBF), acupuncture, tongue pressure resistance feedback (TPRF), botulinum toxin type A (BTX-A), and transcranial direct current stimulation (tDCS). No comparator group was reported in the included evidence.

Regarding the primary outcome of effective rate, balloon dilation combined with rTMS demonstrated the highest value at 91.8%, followed by balloon dilation combined with EMGBF at 82.8% and balloon dilation combined with acupuncture at 79.4%. These rankings were based on SUCRA values. For the videofluoroscopic swallowing study (VFSS) score, balloon dilation combined with acupuncture achieved 92.0%, followed by balloon dilation combined with TPRF at 79.6% and balloon dilation combined with BTX-A at 78.4%.

Secondary outcomes included the Functional Oral Intake Scale (FOIS) score and the Standardized Swallowing Assessment (SSA) score. For FOIS, balloon dilation combined with BTX-A scored 87.4%, followed by tDCS at 83.0% and acupuncture at 76.8%. Conversely, for SSA scores, balloon dilation combined with acupuncture scored 80.0%, followed by BTX-A at 69.5% and rTMS at 68.5%. All results were derived from SUCRA values without reported absolute numbers or confidence intervals.

Safety and tolerability data were not reported, including adverse events, serious adverse events, discontinuations, or general tolerability. Key limitations included small sample sizes of included studies, inadequate allocation concealment and blinding, and potential publication bias for some outcomes. The practice relevance indicates that intervention efficacy varied across different outcome measures. Clinicians should interpret these findings with caution given the methodological constraints and lack of safety information.

The stroke symptom nobody likes to talk about

When people imagine stroke recovery, they picture weakness on one side, slurred words, maybe a walking cane. Few imagine what happens at the dinner table. But for many survivors, the scariest lingering problem is swallowing — specifically, a condition called cricopharyngeal achalasia.

The name sounds clinical, but the experience is not. The cricopharyngeus is a ring-shaped muscle at the top of the esophagus that normally relaxes when you swallow to let food pass. After some strokes, it forgets how. It stays tight. Food and liquid hit it and either pool above or sneak into the airway. Meals become dangerous. Pneumonia becomes a recurring visitor. Nutrition falls off.

Why now

This problem has had a patchwork of treatments for years, and clinicians have argued about which work best. A Chinese research team just published the first large network meta-analysis on it — the kind of statistical tool that ranks treatments even when they were never tested directly against one another.

They combed 10 databases and trial registries through December 2025, pulled 36 randomized trials, and compared 13 different interventions across four swallowing outcome measures. No prior review had mapped the field this completely.

The treatments in the ring

Most approaches start from the same base: balloon dilation, where a thin balloon is eased past the tight muscle and gently inflated to stretch it open. Used alone, it helps — but most of the trials in this analysis paired dilation with something else. The add-ons included:

  • rTMS (repetitive transcranial magnetic stimulation, a non-invasive brain-nudging device)
  • Acupuncture
  • Botulinum toxin (Botox) injection into the muscle
  • EMG biofeedback (seeing your own muscle activity on a screen)
  • tDCS (transcranial direct current stimulation)
  • Tongue-pressure resistance training

The winners depend on what you are measuring

Here is where this study gets genuinely useful — the best treatment changes based on what problem you are trying to solve.

For an overall "it worked" measure, the top combination was balloon dilation plus rTMS — the brain-stimulation add-on. Ranking probability: 91.8%.

For the VFSS score, a videofluoroscopy-based imaging test that shows how food actually moves through the throat, balloon dilation plus acupuncture took the top spot at 92%.

For FOIS, the functional scale that tracks what real foods and drinks a patient can safely eat, balloon dilation plus Botox led at 87.4%.

For the SSA swallowing safety score, acupuncture again topped the list at 80%.

Why do the winners change?

Each outcome measures a different slice of the swallowing problem. Videofluoroscopy cares about physical movement of the muscle. FOIS cares about daily eating. The effective-rate scale blends everything. Brain stimulation, needles, and Botox all work through different mechanisms, so it makes sense they would each shine in different lanes.

For clinicians, this is actually clarifying rather than confusing — it means the treatment plan can be tailored to the patient's biggest problem.

Re-engaging with what it means

A patient who is aspirating liquids and losing weight cares most about the FOIS outcome — can they eat real food again? The review points toward balloon dilation plus Botox.

A patient who passes the eating test but whose imaging still shows a sluggish muscle may benefit more from the acupuncture pairing.

And for patients whose overall recovery has stalled, rTMS is the pairing with the strongest "it worked" signal.

If you or a loved one is recovering from stroke with persistent swallowing trouble, three things follow from this research:

1. Ask specifically about combination therapy. Balloon dilation alone often does not bring patients back to normal eating. The add-on matters. 2. Know which outcome your team is tracking. If they only watch one score, you may miss improvements in another. 3. Acupuncture shows up twice in the top rankings. It is worth asking whether your rehab center offers it in combination with dilation.

Brain stimulation devices are not yet everywhere, but more rehab centers are adding them each year.

The limitations worth naming

The authors are careful to warn readers. Many included trials had small samples, weak allocation concealment, and blinding challenges that are nearly impossible to solve when one treatment involves needles and another involves a magnetic device. Publication bias may have nudged some outcomes higher than they deserve.

Translation: the rankings are a useful map, not a verdict. A treatment at the top of one list might slide down once better-designed trials arrive.

What this field needs next is direct, head-to-head comparisons — ideally between the top two or three combinations on FOIS, which is the outcome that most matters to patients' daily lives. Larger sample sizes and sham-controlled designs for the brain stimulation arms would also tighten the evidence.

For now, the message is hopeful: post-stroke swallowing problems are not a dead end. There is a menu of add-on therapies, and at least some of them are beating dilation alone.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study aims to employ network meta-analysis to systematically compare and evaluate the efficacy of various interventions for post-stroke cricopharyngeal achalasia.MethodsWe searched 10 databases and trial registries from inception to December 3, 2025, to identify randomized controlled trials (RCTs) on cricopharyngeal achalasia after stroke. Two investigators independently screened studies, extracted data, and assessed risk of bias. The outcome indicators included effective rate, videofluoroscopic swallowing study (VFSS) score, Functional Oral Intake Scale (FOIS) score, and Standardized Swallowing Assessment (SSA) score.ResultsA total of 36 articles covering 13 interventions were included. Network meta-analysis revealed: ① Regarding the evaluation of effective rate, the top three interventions based on SUCRA values were: balloon dilation combined with repetitive transcranial magnetic stimulation (rTMS) (91.8%) > balloon dilation combined with electromyographic biofeedback (EMGBF) (82.8%) > balloon dilation combined with acupuncture (79.4%); ② For the VFSS assessment, the highest SUCRA rankings were: balloon dilation combined with acupuncture (92.0%) > balloon dilation combined with tongue pressure resistance feedback (TPRF) (79.6%) > balloon dilation combined with botulinum toxin type A (BTX-A) (78.4%); ③ Concerning the FOIS evaluation, the top three SUCRA values were: balloon dilation combined with BTX-A (87.4%) > balloon dilation combined with transcranial direct current stimulation (tDCS) (83.0%) > balloon dilation combined with acupuncture (76.8%); ④ In the SSA evaluation, the leading interventions by SUCRA were: balloon dilation combined with acupuncture (80.0%) > balloon dilation combined with BTX-A (69.5%) > balloon dilation combined with rTMS (68.5%).ConclusionIntervention efficacy varied across outcome measures. Balloon dilation combined with acupuncture may be the optimal intervention for improving VFSS scores and reducing SSA scores. Balloon dilation combined with BTX-A may be optimal for improving FOIS scores, and balloon dilation combined with rTMS may be optimal for increasing the effective rate. However, given the small sample sizes of included studies, inadequate allocation concealment and blinding, and potential publication bias for some outcomes, the present findings should be interpreted with caution. Further high-quality studies are warranted to validate these results.Systematic review registrationThis systematic review has been prospectively registered in PROSPERO. Identifier CRD420251186725.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.